Cancer Treated With Pottali, Ayurvedic Injections Under Development, and Tridosha at the Cellular Level: What Patanjali University, Moksha Ayurveda Hospital, Quadra Medical Institute, and Ayurveda Kumbh Showed Parul University BAMS Students About Where Ayurveda Is Heading.

Every student who is studying Ayurveda gets one question from their friends and relatives: “Is Ayurveda effective?” And this question is relevant because in today’s time, when sonography, MRI, etc. are there to detect diseases, it is important to understand where our traditional medicines stand.

The answer requires evidence, not sentiment. The four institutions Parul University students visited in Haridwar provide that evidence through research collaborations, clinical innovation, and therapeutic approaches that are being validated by modern science.

Full Ayurveda Tour: Also Check the 7-Session Complete Guide.

Usually, the Ayurvedic practices and medicines are viewed as traditional substitutes, but Prof. Mayank Kumar Agrawal (Pro Vice Chancellor, University of Patanjali) presented them as a system of scientific approvals. This university collaborates with AIIMS to research and formulate new medicines and practices. The approval path appears to be clear with the identification of the traditional treatment that works clinically, testing it through the modern research methodology, publishing results, and compiling the evidence that regulatory bodies and international health systems require.

The results are already visible. Ayurveda is gaining formal acceptance in Sri Lanka and Australia. Prof. Agrawal projected recognition in the UK and Germany within the coming decade. Wellness tourism, driven by international patients seeking authentic Ayurvedic treatment, contributes approximately 5.7 percent of Uttarakhand’s GDP. These are not aspirational claims. They are economic indicators.

He talked about the Rasa Aushadhis and the therapeutic potential of these medicines and shared a real-life case where a patient, Amit Vadiya, recovered from cancer. The role of mental and emotional state is also required to cure such diseases.

Dr. Ramakant Marde (Dean of PG Studies) and Dr. C.B. Dhanraj (Director of PG Studies) provided the theoretical and research framework that underlies clinical practice.

Tridosha: Not Philosophy, Physiology

In the session Tridosha was explained not as an abstract philosophical concept but as the most important factor to help cure diseases. Through vata, pita, and kapha (the three governing principles of the body), major body issues can be solved. The treatment focuses on restoring the balance of these three to keep the body aligned.

For BAMS students, this reframing is critical. Tridosha is not something to memorize for examinations. Trisdosha is a diagnostic framework combined with therapeutic assistance that guides the clinical decisions.

Rasayana: Preventive and Restorative

This therapy believes in prevention and restoration, wherein there are practices, methods, and medicines to improve immunity, increase longevity, and build overall vitality.

This positions Rasayana in the same space that modern preventive medicine occupies: maintaining health before disease occurs. The speakers connected this directly to dietary regulation, arguing that food itself acts as medicine and that treatment is incomplete without proper dietary management.

In-Silico Research: Where Tradition Meets Computation

In this research method, quantitative analysis can be gained, and simulated practices are carried out to identify how Ayurvedic formulations interact with the biological systems.

This approach bridges traditional knowledge and modern scientific validation by allowing researchers to test hypotheses digitally before conducting clinical trials. For Ayurveda’s credibility in international healthcare, in-silico validation is a significant step because it speaks the language of evidence that global regulatory authorities understand.

Dr Uttam Kumar (anorectal surgeon and Ayurvedic specialist) demonstrated how Ayurveda functions in a hospital environment where patients present with real conditions requiring practical solutions.

Ayurvedic Injection: Modernising Drug Delivery

Most of the older patterns relied on oral intake and preparations like tablets, powder, etc and now developing an injectables leads to effective treatment in the modern clinical systems.

This is not about abandoning tradition. It is about expanding the delivery mechanisms so that the active principles in Ayurvedic formulations can reach patients faster and more precisely.

Yukti: The Practitioner’s Judgment

Dr. Uttam Kumar emphasised that every medicine should be modified using the practitioner’s own Yukti (logical reasoning). Ayurveda is not a formulary to follow blindly. Each patient’s constitution, condition, and response requires individual adaptation. Specific preparations discussed included Sapta Amruta Loha (an iron-based formulation for anaemia and hair loss) and herbs like Manjishta and Asaka for skin diseases and infections. The hospital treats liver disorders, hepatitis, and burn cases using tailored Ayurvedic management.

Dr. Rishabh Jain (Dean, Quadra Medical Institute) added the conceptual depth that connects classical Ayurveda with modern cell biology. His session on Prameha (diabetes) described it as a group that requires variations to suit the individual, which is based on the patient’s body buildup and disease stage.

The key concept was Strotas: internal channels that facilitate the movement of nutrients, fluids, and waste within the body. Any disruption or blockage in these channels contributes to disease development. This is not merely a philosophical idea.

It draws similarities between the modern methods of treatment and Ayurvedic treatment. Dr. Jain explicitly linked Ayurvedic treatment to the cellular level, helping students visualize how herbal formulations interact with biological systems.

Dr. Gopi Krishna (Ayurveda Specialist) introduced Pottali preparation, one of the most advanced and specialized areas of Ayurvedic therapeutics. Pottali involves meticulous combinations of herbs and minerals where each step in preparation directly affects potency and effectiveness. These are not routine medicines but require significant expertise and precision.

The application in cancer treatment was discussed through a case study where Pottali preparation contributed to disease management. Combined with the Rasa Aushadhi discussion at Patanjali University and the Amit Vaidya cancer recovery case, students saw three perspectives on the same question: can Ayurveda address serious diseases? The emerging answer is that specialized branches of Ayurveda (Rasa Shastra, Pottali, and advanced formulations) are actively being applied to critical conditions, though continued research and validation remain essential.

The five evidence streams from Haridwar form a coherent picture: Ayurveda is not defending its relevance. It is expanding its evidence base. Globalisation is happening through research, not marketing. Clinical innovation (Ayurvedic injections) is happening in hospitals, not in startups. Computational validation (in-silico) is happening alongside traditional clinical observation. And the foundational concepts (Tridosha, Strotas, Rasayana) are being connected to modern physiology and cell biology, not replacing them.

Parul University’s BAMS programme operates within this trajectory. The university’s Parul Ayurved Hospital, the first NABH-accredited Ayurveda teaching hospital in Gujarat (268 IPD beds, 9 speciality OPDs), provides the clinical infrastructure where students apply what they study. The Haridwar tour extends that clinical exposure to institutions at the frontier of Ayurvedic research and innovation. The university’s mission goes beyond producing Ayurvedic practitioners who pass examinations. It aims to build practitioners who can contribute to the scientific validation and clinical expansion of Ayurveda in the decades ahead.

Also check how students work with PIERC: 254 Startups.